Replies to post #335773 on Bioelectronics Corp (BIEL)

[Just No]

What makes Salonpas “inferior”?

Certainly not it’s revenue.

It is clinically proven to be effective.
It is FDA cleared.
It is endorsed by a pain specialist.
It has an effective marketing strategy.
It’s parent company has a $2 billion market cap.
People like it and use it…repeatedly.

Which part is inferior?